Abstract
A recent randomized controlled trial suggests that hypothyroid subjects may find levothyroxine (l-T4) and levotriiodothyronine combination therapy to be superior to l-T4 monotherapy in terms of quality of life, suggesting that the brain registered increased T3 availability during the combination therapy.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Endocrine Connections |
Vol/bind | 2 |
Udgave nummer | 1 |
Sider (fra-til) | 55-60 |
Antal sider | 6 |
ISSN | 2049-3614 |
DOI | |
Status | Udgivet - 1 mar. 2013 |